speb/financial-data huggingface dataset:
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 55330000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Interest Expense: 59142000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 16147000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 59142000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 16147000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Interest Income: 1702000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 1702000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -59142000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Interest Paid Cfo: -153000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Inventory: 60315000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 60315000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 659696000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 659696000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -49696000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 28541000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 28541000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 484187000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 484187000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 450000000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 450000000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 1612500000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1612500000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2062500000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2062500000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 30609000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 30609000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 2130149000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2130149000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Net Debt: 2121850000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 2121850000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Net Income: -269393000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Net Income: -82684000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -269393000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -82684000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -269393000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -82684000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: 0.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -269393000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -82684000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -269393000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -82684000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -269240000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -269393000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -82684000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Net Interest Income: -59142000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -16147000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 187789000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -222500000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -59142000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -16147000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 1000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -15699000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Net PPE: 1467697000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 1467697000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -33997000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 410289000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: -1485581000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -1485581000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 30609000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 30609000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 40674000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 40674000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: -143206000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -50694000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Normalized Income: -269393000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Normalized Income: -82684000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -78910000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Operating Income: -217189000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Operating Income: -69771000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Operating Revenue: 433119000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 61000000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 21560586.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 21560586.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 38398000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 38398000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 154640000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 154640000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 3938000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 3938000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 23193000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 23193000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 59142000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: -4000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: -4000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 450001000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 450001000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 7089000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 3380000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 361875000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 74871000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Other Payable: 181616000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 181616000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Other Properties: 223531000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 223531000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 1741000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1741000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 1962000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1962000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Other Special Charges: -1221000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Payables: 363141000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Payables: 363141000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7896000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7896000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 38619000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 38619000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Pretax Income: -269240000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Pretax Income: -82531000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -721000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -35632000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 24286000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 24286000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 55557000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5670000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 66892000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 15690000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 6609000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1182000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1182000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -2972616000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -2972616000.00
KREBSBIO.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 1635000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 9402000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Share Issued: 21560586.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 21560586.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: -1462388000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -1462388000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: -1485581000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -1485581000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Tax Provision: 153000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 153000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Total Assets: 1690356000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1690356000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 150112000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 150112000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Total Debt: 2572084000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2572084000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: -1462388000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -1462388000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Total Expenses: 650308000.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 130771000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 3152744000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3152744000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 1587765000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1587765000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2117483000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2117483000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 59000.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
KREBSBIO.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 24374000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 24374000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Work In Process: 35435000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 35435000.00
KREBSBIO.NS balance_sheet (annual, 2025-03-31) — Working Capital: -932670000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: -932670000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 88776000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 54809000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 21555870.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -2.47
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2892000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 15987000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 15987000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 21555870.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -2.47
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -53243000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — EBIT: -36742000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — EBITDA: -20755000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 51917000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 16501000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 16501000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Net Income: -53243000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -53243000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -53243000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -53243000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -53243000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -53243000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -16501000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -16501000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -20755000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -53243000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Operating Income: -36859000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 54809000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 117000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 45278000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Pretax Income: -53243000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2892000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 15987000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 91668000.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 85824000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 41674000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 174802000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1415000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 28540000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 21553684.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -2.85
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 215606000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1271000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1594000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 215606000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -1577061000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 12403000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 16000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 101731000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 556355000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 556355000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1115702000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 13904000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 16243000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 16243000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 21553684.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -2.85
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -61428000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — EBIT: -44099000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — EBITDA: -27856000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 22271000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1453935000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 41658000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 17329000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 17329000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 57738000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 617294000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 28540000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1638000000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1638000000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 30609000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2193084000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Net Income: -61428000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -61428000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -61428000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -61428000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -61428000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -61428000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -17329000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -17329000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 1453935000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -1599332000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -27856000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Normalized Income: -61428000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Operating Income: -44166000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 41674000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 21560586.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 40984000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 163044000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -1792667000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 22271000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 73836000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 450001000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 67000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 42683000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 1441532000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 323000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Payables: 174802000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -61428000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 16000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 16243000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 21560586.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -1577061000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -1599332000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 1680313000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 60939000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2194355000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -1577061000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 85840000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3257374000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1578582000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2141672000.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
KREBSBIO.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: -1013971000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 86103000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 72742000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 162178000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 500000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 28601000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 21562069.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -1.45
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 215606000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1475000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1782000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Common Stock: 215606000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -1608325000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 12403000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 17000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Current Assets: 97765000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Current Debt: 564724000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 564724000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1116130000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Current Provisions: 12930000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 16346000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 16346000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 21562069.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.45
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -31265000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — EBIT: -13336000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — EBITDA: 3010000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 21807000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1435405000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 72725000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 17929000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 17929000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Inventory: 57664000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 606399000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 28601000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1650000000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1650000000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 30609000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Net Debt: 2213249000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Net Income: -31265000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -31265000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -31265000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -31265000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -31265000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -31265000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -17929000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -17929000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Net PPE: 1435405000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -1630132000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 3010000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -31265000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Operating Income: -13378000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 72742000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 21560586.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 37819000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 158370000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -1823931000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 21807000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 75562000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 450000000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 43000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 42832000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Other Properties: 1423002000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 307000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Payables: 162178000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -31265000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 17000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 16346000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Share Issued: 21560586.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -1608325000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -1630132000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Total Assets: 1659140000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 41675000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Total Debt: 2214724000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -1608325000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 86120000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3267465000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1561375000.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2151335000.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
KREBSBIO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
KREBSBIO.NS balance_sheet (quarterly, 2025-12-31) — Working Capital: -1018365000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — +Operating Expense: 352145000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 91442000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — +Total Revenue: 237316000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 68091000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 137584000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 137584000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 43000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 43000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 27136000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 27136000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 21464220.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -1.09
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1416000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -31715000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 215606000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 215606000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1291000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1291000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 3128000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 3128000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 3279000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -1352000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 36983000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Change In Payable: -29168000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 2425000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 11223000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -125000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Common Stock: 215606000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 215606000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: -1627547100.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -1627547100.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 15868000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 15868000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 3906000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 981000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Current Assets: 96222000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 96222000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Current Debt: 612882000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 612882000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 612882000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 612882000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1130658000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1130658000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 6953000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 6953000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Depreciation: 64233000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 64233000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 64233000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 15657000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 64233000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 15657000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 21464220.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.09
KREBSBIO.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -169331000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -23396000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — EBIT: -98472000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — EBIT: -4296000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — EBITDA: -34239000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — EBITDA: 11361000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1291000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 55438000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -50920000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 329000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2883000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2883000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 1430073000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1430073000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Gross Profit: 233410000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 67110000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Interest Expense: 70859000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 19100000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 70859000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 19100000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -70859000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Interest Paid Cfo: 0.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Inventory: 57036000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 57036000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 620834900.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 620834900.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -36358000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 27136000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 27136000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 1635500000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1635500000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1635500000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1635500000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 27774000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 27774000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Net Debt: 2247091000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 2247091000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Net Income: -169331000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Net Income: -23396000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -169331000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -23396000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -169331000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -23396000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -169331000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -23396000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -169331000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -23396000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -169331000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -169331000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -23396000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Net Interest Income: -70859000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -19100000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 126298000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 23000000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -70859000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -19100000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -1000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -8292000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Net PPE: 1430073000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 1430073000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -28066000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 103298000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: -1630430100.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -1630430100.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: -34239000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 11361000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Normalized Income: -169331000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Normalized Income: -23396000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -19205000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Operating Income: -118735000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Operating Income: -24332000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Operating Revenue: 237316000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 68091000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 21560586.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 21560586.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 36015000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 36015000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 149337000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 149337000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: -1843153100.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -1843153100.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 2883000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2883000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 52313000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 76153000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 76153000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 450000000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 450000000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 20263000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 20036000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 184032000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 53239000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Other Properties: 1414205000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 1414205000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 1837000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1837000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Payables: 137584000.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Payables: 137584000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Pretax Income: -169331000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -23396000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 1336000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -31715000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 3906000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 981000.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 64233000.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 15657000.00
KREBSBIO.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 3649000.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Share Issued: 21560586.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 21560586.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: -1627547100.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -1627547100.00
KREBSBIO.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: -1630430100.00
KREBSBIO.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -1630430100.00
KREBSBIO.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
KREBSBIO.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00